Vincenzo Fontana

Medicine & Life Sciences

1. Malignant Mesothelioma 100%
2. mesothelin 98%
3. Pleural Effusion 75%
4. Barrett Esophagus 75%
5. Ipilimumab 75%
6. Breast Neoplasms 73%
7. Italy 71%
8. Mesothelioma 70%
9. Biomarkers 66%
10. Fenretinide 62%
11. Survival 60%
12. Case-Control Studies 58%
13. Neoplasms 58%
14. Esophagitis 52%
15. Neuroblastoma 48%
16. Leukemia 46%
17. Melanoma 45%
18. Circulating Neoplastic Cells 38%
19. Occupational Groups 37%
20. Lung Neoplasms 35%
21. Non-Small Cell Lung Carcinoma 34%
22. Non-Hodgkin's Lymphoma 34%
23. Air Pollution 34%
24. Mortality 34%
25. Cell Biology 29%
26. Alcohol Drinking 28%
27. Asbestos 27%
28. Serum 27%
29. Tamoxifen 26%
30. Biological Monitoring 25%
31. Tea 25%
32. Population 24%
33. Prostatic Neoplasms 24%
34. Urinary Bladder Neoplasms 24%
35. Fibrin 24%
36. Drug Therapy 23%
37. Retinoids 23%
38. Styrene 21%
39. liposomal doxorubicin 21%
40. Benzene 21%
41. CTLA-4 Antigen 21%
42. Doxorubicin 21%
43. Wine 21%
44. Malignant Pleural Effusion 21%
45. Peptides 21%
46. Nivolumab 21%
47. Raloxifene Hydrochloride 21%
48. Stomach Neoplasms 21%
49. Sister Chromatid Exchange 20%
50. T-Lymphocytes 20%